Mathilde Mejer

Mathilde Mejer has extensive experience in the pharmaceutical and healthcare industry. Mathilde currently holds the position of Head of Health at Matas A/S, where they are responsible for overseeing health-related operations. Prior to their current role, they served as the Head of Medicare/OTC at the same company.

Before joining Matas A/S, Mathilde worked at Tjellesen Max Jenne A/S as a Mærkevarechef from 2018 to 2022. Mathilde'sresponsibilities included managing brand development and strategy.

From 2016 to 2018, Mathilde was the Head of Marketing OTC at Mylan, where they were responsible for the company's OTC portfolio, business development, concept, and strategy. Mathilde also handled marketing materials, negotiations with pharmacies and retailers, and the digital strategy. Mathilde joined Mylan through the acquisition of Meda, where they worked as an Area Business Manager from 2011 to 2016.

Mathilde's career began at Antula Healthcare AB in 2006, where they served as the Sales Manager. Mathilde was in charge of establishing OTC sales channels, managing wholesalers, and leading a team of sales representatives. Prior to that, they worked as a Distriktschef at Johnson & Johnson from 2002 to 2006 and as an Apotekskonsulent at Pharma Vinci from 2001 to 2002.

Mathilde gained experience in the pharmaceutical industry early in their career, serving as a Ledende Farmakonom at Roskilde Dom Apotek from 1997 to 2001 and as a Farmakonom at Rødovre Apotek from 1991 to 1997.

Mathilde Mejer attended Kolding Gymnasium from 1989 to 1991, where they completed their student degree with a focus on sproglig (linguistic) studies. Following their time at Kolding Gymnasium, Mathilde attended Farmakon from 1991 to 1994, where they obtained a Farmakonom degree. Unfortunately, the field of study for their Farmakonom degree is not provided.